Zhanar Balmukhamedova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhanar Balmukhamedova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ayagyoz Umbetzhanova
Department of Family Medicine No. 1, Astana Medical University, Astana, Republic of Kazakhstan
1 shared publication - Ayan Abdrakhmanov
Heart Rhythm Scientific Research Institute, Astana Medical University, Astana, Kazakhstan
1 shared publication Dariga Blyalova
NJSC “Astana Medical University”, NJSC “National Scientific Cardiac Surgery Center”, Astana, Kazakhstan
1 shared publication- Dariga Blyalova1 shared publication
Germanas Marinskis
NJSC “Astana Medical University”, NJSC “National Scientific Cardiac Surgery Center”, Astana, Kazakhstan
1 shared publication- Germanas Marinskis
Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Santariškių str. 2, LT-08661 Vilnius, Lithuania
1 shared publication
Latest Publications
- Open Access
- 29 September 2024
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 122 (3) , 12-18
Prognostic Significance of Structural and Functional Indicators of Myocardial Dysfunction in Postmenopausal Women: Current Perspectives
Menopause represents a significant period in a woman’s life, marked by substantial hormonal changes that significantly impact various bodily systems, particularly the cardiovascular system. The cessation of estrogen production increases the risk of cardiovascular diseases, including myocardial dysfunction. Myocardial dysfunction during menopause may lead to heart failure, particularly in postmenopausal women, where cardiovascular events become more frequent. This condition poses a serious health concern as structural and functional heart changes may remain undetected until advanced stages, complicating diagnosis and treatment. The relevance of studying myocardial dysfunction in menopausal women lies in the profound hormonal and physiological changes occurring during this period. Loss of estrogen's protective effect contributes to increased risks of hypertension, myocardial hypertrophy, and diastolic dysfunction, even with preserved ejection fraction, complicating diagnosis and management. The pathophysiology of myocardial dysfunction involves endothelial dysfunction, exacerbated by reduced nitric oxide synthesis and lipid metabolism disruptions, further promoting myocardial hypertrophy and fibrosis. Epidemiological data reveal a higher incidence of heart failure with preserved ejection fraction (HFpEF) in postmenopausal women, linked to more pronounced diastolic dysfunction compared to men.Diagnostic methods like echocardiography and advanced imaging techniques such as MRI play a crucial role in identifying early structural myocardial changes, including left ventricular hypertrophy and fibrosis. Understanding the prognostic significance of these structural and functional myocardial indicators is critical for preventing cardiovascular diseases and improving patient outcomes in menopausal women.
- 29 September 2024
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 122 (3) , 12-18
Open AccessPrognostic Significance of Structural and Functional Indicators of Myocardial Dysfunction in Postmenopausal Women: Current Perspectives
Menopause represents a significant period in a woman’s life, marked by substantial hormonal changes that significantly impact various bodily systems, particularly the cardiovascular system. The cessation of estrogen production increases the risk of cardiovascular diseases, including myocardial dysfunction. Myocardial dysfunction during menopause may lead to heart failure, particularly in postmenopausal women, where cardiovascular events become more frequent. This condition poses a serious health concern as structural and functional heart changes may remain undetected until advanced stages, complicating diagnosis and treatment. The relevance of studying myocardial dysfunction in menopausal women lies in the profound hormonal and physiological changes occurring during this period. Loss of estrogen's protective effect contributes to increased risks of hypertension, myocardial hypertrophy, and diastolic dysfunction, even with preserved ejection fraction, complicating diagnosis and management. The pathophysiology of myocardial dysfunction involves endothelial dysfunction, exacerbated by reduced nitric oxide synthesis and lipid metabolism disruptions, further promoting myocardial hypertrophy and fibrosis. Epidemiological data reveal a higher incidence of heart failure with preserved ejection fraction (HFpEF) in postmenopausal women, linked to more pronounced diastolic dysfunction compared to men.Diagnostic methods like echocardiography and advanced imaging techniques such as MRI play a crucial role in identifying early structural myocardial changes, including left ventricular hypertrophy and fibrosis. Understanding the prognostic significance of these structural and functional myocardial indicators is critical for preventing cardiovascular diseases and improving patient outcomes in menopausal women.
- Open Access
- 1 January 2022
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 10 (B) , 1-6
Some Echocardiographic Indicators as Probable Predictors of Atrial Fibrillation Recurrence in Patients with Arterial Hypertension after Catheter Ablation
The work is devoted to the study of possible predictors of atrial fibrillation (AF) recurrence after interventional procedures. Purpose: to study the echocardiographic predictors of AF recurrence in patients with arterial hypertension after pulmonary veins catheter ablation.
- 1 January 2022
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 10 (B) , 1-6
Open AccessSome Echocardiographic Indicators as Probable Predictors of Atrial Fibrillation Recurrence in Patients with Arterial Hypertension after Catheter Ablation
The work is devoted to the study of possible predictors of atrial fibrillation (AF) recurrence after interventional procedures. Purpose: to study the echocardiographic predictors of AF recurrence in patients with arterial hypertension after pulmonary veins catheter ablation.